Answers are grounded in this paper and cite their sources.
Background Tamogitake (Golden Oyster Mushroom) is an edible mushroom rich in ergothioneine, a sulfur-containing amino acid. It has been reported that ergothioneine exerted beneficial effects such as anti-inflammatory properties and improvement of cognitive function via its potent antioxidant activity. However, the benefits of dietary Tamogitake supplementation remain unclear. In this study, we investigated the effects of Tamogitake powder or ergothioneine intake on lipid metabolism in rats and mice. Methods In experiment 1, four-week-old male Sprague-Dawley rats were fed AIN-76 based diets containing 5% Tamogitake dried-powder supplemented with or without 0.5% cholesterol for 4 weeks. The parameters involved in lipid metabolism were measured in the serum and liver. Hepatic mRNA expression levels of genes involved in cholesterol metabolism were also analyzed. In experiment 2, three-week-old male KK- A y mice, a model of obesity and hyperglycemia, were fed diets containing 5% Tamogitake powder or 0.05% ergothioneine with 0.5% cholesterol for 52 days. Serum and liver parameters and fecal lipid excretion were measured. Results In experiment 1, liver weight and hepatic cholesterol and triacylglycerol levels were significantly reduced in SD rats fed diets containing Tamogitake with or without cholesterol. Tamogitake did not affect hepatic mRNA expression of HMG-CoA reductase or CYP7A1 in rats. In experiment 2, the lowering effect of Tamogitake intake on hepatic cholesterol and triacylglycerol levels was reproduced in KK- A y mice even though their livers accumulated excess lipids; however, this effect was not observed in mice fed the ergothioneine diet. Fecal excretion of apparent total cholesterol and free fatty acids, but not bile acids, tended to be promoted by Tamogitake feeding but not by ergothioneine feeding. Blood glucose and serum insulin levels were not significantly different among groups. Conclusions The suppressive effect of Tamogitake feeding on hepatic lipid accumulation was demonstrated for the first time in rats and mice. Also, fecal excretion of apparent total cholesterol and free fatty acids tended to be promoted by Tamogitake feeding. These effects cannot be attributed to ergothioneine alone.
No takes yet. Share an insight, caveat, or question.
Hase-Tamaru et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: